Literature DB >> 17253955

Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors.

Yi Wei Zhang1, Jerrod Denham, R Scott Thies.   

Abstract

Oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem (hES) cells have been reported to remyelinate axons and improve locomotor function in a rodent model of spinal cord injury. Although remyelination would be expected to have a beneficial effect in spinal cord injury, neurotrophic factor expression may also contribute to functional recovery. Neurotrophic factors could impact the survival of axotomized neurons, as well as promote axonal regeneration in interrupted conduction pathways. This study demonstrates that hES cell-derived OPCs express functional levels of midkine, hepatocyte growth factor (HGF), activin A, transforming growth factor-beta2 (TGF-beta2), and brain-derived neurotrophic factor (BDNF), proteins with reported trophic effects on neurons. The neurotrophic activity of hES cell-derived OPCs is further demonstrated by stimulatory effects on neurite outgrowth of adult rat sensory neurons in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17253955     DOI: 10.1089/scd.2006.15.943

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  42 in total

1.  Retroviral infection of hES cells produces random-like integration patterns.

Authors:  Kwang-il Lim
Journal:  Mol Cells       Date:  2012-04-20       Impact factor: 5.034

Review 2.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

3.  Transient changes in spinal cord glial cells following transection of preganglionic sympathetic axons.

Authors:  Aminata P Coulibaly; Lori G Isaacson
Journal:  Auton Neurosci       Date:  2012-01-29       Impact factor: 3.145

Review 4.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

5.  Neural stem cells for Parkinson's disease: to protect and repair.

Authors:  Paul R Sanberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

Review 6.  Oligodendroglial cells and neurotrophins: a polyphonic cantata in major and minor.

Authors:  Hans H Althaus; Sabine Klöppner; Steve Klopfleisch; Matthias Schmitz
Journal:  J Mol Neurosci       Date:  2008-03-08       Impact factor: 3.444

7.  Stem cells: A time to heal.

Authors:  Cassandra Willyard
Journal:  Nature       Date:  2013-11-14       Impact factor: 49.962

8.  Cellular environment directs differentiation of human umbilical cord blood-derived neural stem cells in vitro.

Authors:  Inga Markiewicz; Joanna Sypecka; Krystyna Domanska-Janik; Tomasz Wyszomirski; Barbara Lukomska
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

9.  Oligodendrocyte-specific loss of Cdk5 disrupts the architecture of nodes of Ranvier as well as learning and memory.

Authors:  Fucheng Luo; Jessie Zhang; Kathryn Burke; Rita R Romito-DiGiacomo; Robert H Miller; Yan Yang
Journal:  Exp Neurol       Date:  2018-05-02       Impact factor: 5.330

10.  Differential cortical neurotrophin and cytogenetic adaptation after voluntary exercise in normal and amnestic rats.

Authors:  J M Hall; R P Vetreno; L M Savage
Journal:  Neuroscience       Date:  2013-11-09       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.